Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
GG1111,
Yes comfortably 14/15p Cathal said there’s serious value in imutex to me in email.
Worth more than current market cap alone but not the $1b press figures.
Also he didn’t think it was worth more than Themis as he believes it went for nearer the £500m mark.
However I’m sure he will do his best for all shareholders here the guy is really trying his best and promoting open orphan the best he can.
Whatever we gets a bonus without all the pieces that can be monetized so overall we are in a great place.
I
It’s all iff,s and buts at the moment, but maybe the 3 presentations coming up over the next few days might give us a clearer picture on what CF,s plans are for ORPH, GLA
It makes things a lot easier for CF I suppose. Maybe Merck might take over the whole OO package. They are a customer atm apparently and maybe sizing the company up?
Tiger, I would say comfortably and being realistic 14/15p ,personally I would prefer the sale rather than the Nasdaq listing
GG, Being in since Hvivo. What's your prediction on Imutex value once floated? A few people been talking it down in here recently.
Personally as a long term sufferer /holder of HVIVO (although this is a horrendous situation the World finds itself in )ORPH is positioned very very nicely indeed.We have a superb team of management under the stewardship of a true Entrepreneur in Cathal Friel ,onwards and upwards.Not to mention a fantastic BB .Was going to say Good Luck to all serious holders ,but we don’t need luck .
Sorry, just on the point of the II out.
I am with you on this one Justdandy ,
Can you explain your reasoning.
Looks like the US institution has eventually sold out as the overhang has cleared. Moving back up to 20p now. Road ahead looks clear. £12m fundraise completed last month, fully funded and opportunities plentiful for OO.